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1. Introduction 
Placenta formation occurs through a complex and coordinated effort between the fetus’s 
extraembryonic tissues and the gravid  endometrial tissues. Many macrophages are 
present in the placenta throughout pregnancy and have been detected as early as day 10 
of pregnancy (Chang et al., 1993). Placental macrophages include Hofbauer cells of the 
fetal chorionic villi and decidual macrophages of the maternal decidua basalis (Figure 1) 
(Bulmer & Johnson, 1984). Functions of placental macrophages include the production of 
substances that regulate local immune reactions (such as factors that regulate maternal 
immunological tolerance and fetal protection) and that promote angiogenesis in the 
placenta during its development (Mues et al., 1989; Sevala et al., 2007). Although they 
represent a significant presence on both the maternal and fetal sides of the placenta, 
placental macrophage functions have not been completely elucidated and still remain a 
significantly studied area of investigation. 
 
Fig. 1. The mesenchymal core of this fetal tertiary chorionic villus contains a Hofbauer cell, 
seen as a large, pale-staining placental macrophage with an eccentric nucleus.  
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2. General placenta function 
The placenta provides an interface for communication between the maternal blood and the 
developing fetus. Substances are selectively transported between the separate but closely 
approximated maternal and fetal vascular systems. Substances exchanged between the fetal 
blood (contained within fetal vessels of chorionic villi) and maternal blood (located within 
sinusoids surrounding villi) include nutrients, waste products, oxygen, carbon dioxide, 
hormones, cytokines, immunoglobulins, drugs, and microbes.  
Signaling molecules found in the placenta, such as hormones and cytokines, are important 
for the maintenance of pregnancy, maternal-fetal tolerance, parturition, lactation, and 
barrier to infection. Placental cells that produce these mediators include fetal trophoblasts 
and placental macrophages. This article is not intended to describe the placenta and all of its 
components in detail, but to discuss one facet of this complex, transient, vital organ of 
pregnancy, the placental macrophage.  
3. Macrophage phenotypes overview 
Human monocytes and macrophages are players in the innate immune system. Macrophages 
are bone marrow/hematopoietic-derived cells that migrate through the blood circulation to 
home to and take up residence within various tissues, where they play a pivotal role in 
coordinating processes such as development and host defense by secretion of cytokines, 
chemokines and growth factors and by phagocytosis. Furthermore, macrophages link the 
innate and adaptive immune systems through phagocytosis, digestion, and antigen 
presentation (macrophage expression of Human Leukocyte Antigen (HLA) class II 
molecules and co-stimulatory receptors such as CD80/CD86) to T lymphocytes. The role of 
macrophages in the orchestration of inflammation, immune responses, and wound 
healing/tissue remodeling has been a field of intensive study.  
Macrophages exhibit great plasticity in their ability to transform between phenotypes. While 
unstimulated, resting macrophages are relatively quiescent and express low levels of 
cytokines and growth factors, activation by agents in the surrounding micro-environmental 
milieu polarizes macrophages to yield a broad spectrum of macrophage phenotypes based 
on location and micro-environmental influences. Environmental stimuli that influence the 
expression of inducible genes and polarization of macrophages may include activating 
agents, pathogens, cytokines, hypoxia, and ischemia (Pinhal-Enfield et al., 2003; 
Ramanathan et al., 2007). 
Based on exposure to surrounding micro-environmental cues, macrophages are induced to 
alter their expression profiles. Two major classifications have been used in the past to 
describe activated macrophages as polarized towards pro-inflammatory or anti-
inflammatory phenotypes. Although categorization of macrophage phenotypes can be 
muddled by assorted combinations of activating agents, macrophages respond to micro-
environmental stimuli and are typically described as “classically”-activated (M1) pro-
inflammatory macrophages or “alternatively”-activated (M2) wound healing macrophages. 
Based on exposure time and the types of activating stimuli, macrophages may switch 
activation state to other phenotypes (Martinez et al., 2009; Daley et al., 2010; Porcheray et al., 
2005; Classen et al., 2009). M1 macrophages induce processes during injury and infection 
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that promote inflammatory processes and promote Th1- type immune responses leading to 
enhanced killing of microbes and tumor cells. M2 macrophages on the other hand, display 
immunosuppressive effects, resolve inflammation through production of anti-inflammatory 
cytokines, enhance phagocytosis and elimination of debris, secrete growth and angiogenic 
factors that stimulate tissue remodeling and repair, and stimulate Th2-type immune 
responses. M2 macrophages are characterized by a distinctive molecular repertoire and have 
been implicated in the down-regulation of inflammation, tissue remodeling, repair, parasite 
killing, allergic reactions, tumor promotion, and placenta formation (Pinhal-Enfield & 
Leibovich, 2011; Leibovich et al., 2010). These descriptions of polarized M1 macrophages or 
M2 macrophages only represent macrophages at the far ends of the spectrum. Macrophage 
phenotypes might be better described as a series of gradations and nuances within a broad 
spectrum between the pro-inflammatory macrophage at one far end and the anti-
inflammatory macrophage at the other end. 
3.1 Induction of macrophage phenotypes 
Heterogenous macrophage populations are found within tissues. These differentiated 
macrophages are plastic and retain the capacity to transform their phenotype in response to 
micro-environmental cues and immune-specific influences. Activated macrophages switch 
phenotypes to develop phagocytic and secretory profiles directed for specific functional 
activities that are in alignment with the original stimuli (Daley et al., 2010).  
Unstimulated macrophages express low levels of inflammatory cytokines and growth 
factors such as tumor necrosis factor-(TNF-), interleukin (IL)-12, and vascular endothelial 
growth factor (VEGF). Stimulation of macrophages with products of pathogenic agents such 
as Toll-like Receptor (TLR) agonists (e.g., lipopolysaccharide (LPS), flagellins, or 
lipoproteins), either with or without interferon-(IFN-) nduces “classical“ M1 activation, 
characterized by production of TNF- and IL-12.  
M2 “alternatively activated“ macrophages are commonly characterized as being induced in 
response to IL-4 and IL-13 through the IL-4 receptor- (IL-4R, and up-regulating 
expression of IL-10, TGF-, and VEGF while down-regulating expression of TNF- and IL-
12 (Martinez et al., 2009; Classen et al., 2009). M2 macrophages also display a series of cell 
surface and intracellular markers (Table 1). Further investigation, however, has revealed 
that IL-4 and IL-13 are not necessary for induction of the M2-like phenotype and mouse 
wounds lacking IL-4/IL-13 still contain M1 and M2-like macrophages (Daley et al., 2010). 
The IL-4/IL-13-independent pathways of alternative macrophage activation that induce 
phenotypes resembling M2 macrophages represent an intense field of study as the 
functional traits of these M2 macrophages and the different activating agents that induce 
them are characterized.  
3.1.1 M1 macrophages 
M1 macrophages promote and coordinate inflammatory processes during injury and 
infection that are essential for intracellular pathogen removal. These macrophages are 
induced by pathogen associated molecular patterns (PAMPs), such as the TLR4 agonist, 
LPS, damage associated molecular patterns (DAMPs), such as those derived from 
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mitochondria of apoptotic neutrophils, and IFN- (produced by activated Th1, Tc1, NK 
cells). Pro-inflammatory and cytotoxic responses against intracellular pathogens and 
transformed cells (such as cancer cells) are directedthrough induction of cytokines (e.g., IL-1, 
IL-6, IL-12, TNF-) and inflammatory mediators (e.g., nitric oxide (NO) through inducible 
NO synthase (iNOS)), and increases in leukocyte recruitment and phagocytic and antigen 
presenting activity. These initial, pro-inflammatory M1 macrophages predominate in the 
early wound, which becomes a dynamic cauldron of mediators that are in constant flux as 
interactions, inductions, and adaptations take place (Martinez et al., 2009; Classen et al., 
2009; VanGinderarchter et al., 2006). In contrast, M2 macrophages are critical for the 
resolution of inflammation and the induction of angiogenesis, tissue remodeling, and repair 
through production of anti-inflammatory cytokines, growth and angiogenic factors, and by 
phagocytosis and elimination of debris (Martinez et al., 2009; Daley et al., 2010; Classen et 
al., 2009; Taylor et al., 2005; Rubartelli et al., 2007; VanGinderarchter et al., 2006). M2 
macrophages are discussed in further detail in the next section.  
 
M1 M2 
INDUCING 
AGENTS 
IFN-, LPS 
IL-4, IL-13 
 IC + IL-1 or TLR agonists 
 GC, IL-10, TGF-
TLR and AR agonists 
UP-
REGULATED 
EXPRESSION 
TNF-, IL-12, IL-1, IL-6, IL-23, 
IP-10, MIP-1, MHC II, CD80, 
collagenase?, A2AR, MMP9, 
NO/iNOS/respiratory burst 
IL-10, IL-1R antagonist, 
 TGF- CD206, CD23,   
AMAC-1. CCL22, CCL17, 
CCL2/MCP-1, IL-1R, 
IL-1 decoy receptor, TGF-,  
Arg-1, Fizz-1, Ym1/Ym2, 
dectin-1, VEGF 
DOWN-
REGULATED 
EXPRESSION 
 
IL-12, TNF- 
GENERAL 
PROFILE 
pro-inflammatory 
anti-inflammatory 
 and wound healing 
Table 1. Inducing agents involved in the regulation of gene expression contribute to the 
development of M1 and M2 macrophage phenotypes. (Martines et al., 2009; Leibovich et al., 
2011). 
3.1.2 M2 macrophages 
Macrophage phenotypes can vary and switch based on temporal and environmental cues, 
making their investigation and classification complex. Wound macrophages in the early 
stages of healing have a more M1-like profile with elevated expression of TNF- and IL-6 
and less TGF-while those in later stages of healing have a more M2-like profile, with less 
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pro-inflammatory cytokine expression, no induction of iNOS, and elevated markers of 
alternative activation, including CD206, dectin-1, arginase-1 (Arg-1), and chitinase 3-like 3 
(Ym1) (Daley et al., 2010; Black et al., 2008)  It is worth noting that the complexity of 
studying alternatively-activated M2 macrophage phenotypes is also attributed to divergent 
profiles in different animal models. While Arg-1 has become a reliable marker of murine M2 
macrophages, it is not a good marker for human M2 macrophages.  
The M2 macrophage phenotype describes a broad category of anti-inflammatory, wound 
healing macrophages that down-regulate effects of pro-inflammatory M1 macrophages and 
have often been described as IL-4/IL-13-dependent. However, both M1 and M2-like 
macrophage phenotypes were also observed in wounds in mice where IL-4 and IL-13 
signaling is absent. Stimulation of macrophages with IL-4 and IL-13 (cytokines produced by 
induced CD4+ Th2 and CD8+ Tc2 cells, NK cells, basophils, mast cells, eosinophils) results 
in “alternative activation“ of macrophages . These “alternatively activated“ macrophages 
were first termed  M2 macrophages, have anti-inflammatory and wound healing properties, 
and are associated with allergic and anti-parasitic responses (Martinez et al., 2009). M2 
macrophages express low levels of pro-inflammatory mediators (such as TNF-, IL-12, IL-
1, IL-8, and oxygen radicals) and express elevated levels of anti-inflammatory cytokines, 
growth factors, and phagocytic receptors such as IL-10, VEGF, TGF-, CD206 mannose 
receptor, and CD204 scavenger receptor (Martinez et al., 2009; Classen et al., 2009;  Stein et 
al., 1992; Abramson and Gallin, 1990). M2 macrophages tailor immune responses by 
chemokine secretion patterns that attract specific sets of leukocytes (monocytes, basophils, 
memory T cells, Th2 cells, and eosinophils). See Table 1 for a list of some M2 macrophage 
markers (Martinez et al., 2009; Classen et al., 2009; Mantovani et al., 2006). In addition to 
their key role in resolving inflammation and mediating repair, M2 macrophages also play a 
role in some pathological processes. Up-regulation of alternative macrophage gene 
expression leads to stifling of Th1 responses and consequent vulnerability to infection, 
allergic responses in asthma, tumor progression assisted by tumor-associated M2-like 
macrophages (TAMs), and fibroproliferative complications of infection and inflammation 
(VanGinderarchter et al., 2006; Mantovani et al., 2006; Luo et al., 2006; Yang et al., 2009; 
Porta et al., 2009; Macedo et al., 2007).  
Further characterization of macrophages has lead to the exploration of other types of 
alternatively activated M2-like macrophages involved in wound healing that are IL-4/IL-13-
independent. The broad category of M2 macrophages has been subdivided based on 
inducing agents and subsequent expression patterns. M2 macrophage subtypes include the 
more commonly investigated M2a macrophage (activated by IL-4 or IL-13), M2b 
macrophage (induced by immune complexes (ICs) and IL-1 or TLR agonists), M2c 
macrophage (stimulated by IL-10, transforming growth factor- (TGF- or glucocorticoids), 
and M2d macrophage (a new subtype induced by switching M1 macrophages into M2-like 
macrophages through initial TLR activation followed by adenosine A2A receptor (A2AR) 
activation) (Figure 2) (Martinez et al., 2009; Leibovich et al., 2011).  
In contrast to the relatively well-characterized M2a macrophage subtype, many M2 
macrophages (M2b, M2c, M2d) are not associated with a Th2 immune response or IL-
4/IL-13 activation. Evidence of this is seen with M2 macrophage activation in IL-4R KO 
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mice and in the presence of the IL-13R2 decoy receptor in spite of inhibition of IL-13-
dependent phosphorylation of downstream STAT6 and the absence of IL-4 or IL-13 in the 
wound environment. These IL-4/IL-13-deficient mice exhibit macrophages with both M1 
and M2 overlapping and non-overlapping expression patterns (Daley et al., 2010; 
Leibovich et al., 2011).  
 
 
Fig. 2. The broad spectrum of macrophage phenotypes induced by various agents show 
overlapping and non-overlapping patterns of gene expression.  
Investigation of the influence of multiple co-stimulators on macrophages allows for some 
insight on downstream signaling pathways and the resulting phenotypic macrophage 
profiles. For example, in the inflammatory environment, the retaliatory metabolite 
adenosine rapidly accumulates extracellularly as an ATP breakdown product and TLRs and 
A2ARs are both expressed on macrophages as important regulators of inflammation and 
repair. Understanding the downstream effects from simultaneous activation of these 
receptors may provide insight on how to enhance or block M2 macrophage effects by 
regulating signaling mediators or using receptor agonists or antagonists. Characterization of 
M2 macrophages by simultaneous induction with multiple agents may more accurately 
mimic true micro-environmental conditions. Co-stimulation of TLRs and A2ARs may be a 
more relevant reflection of macrophage surroundings, where adenosine accumulation 
occurs in inflammatory, ischemic, and hypoxic settings, leading to phenotype switching 
from TLR agonist-induced pro-inflammatory M1 macrophages (secrete TNF- and IL-12) to 
adenosine-induced wound healing and anti-inflammatory M2d macrophages (down-
regulation of TNF- and IL-12 and secretion of IL-10 and VEGF) in a temporally defined 
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manner. This induction of A2ARs plays a key role in switching pro-inflammatory M1 to an 
angiogenic M2-like phenotype. Solitary activation of these receptors may not show 
expression patterns seen in co-stimulation models. This example of receptor co-stimulation 
on macrophages shows that macrophage activation and its role in wound healing is a 
complex event involving multiple micro-environmental stimuli (Leibovich et al., 2011; 
Macedo et al., 2007). Knowledge of the processes leading to the phenotypic switches 
occurring in macrophages may yield potential therapeutic targets for promoting wound 
healing or for dampeningabnormal wound healing. Although macrophages have varying 
and dynamic roles that adapt to activating agents in the surrounding milieu, a clear 
understanding of how to manipulate and switch these phenotypic profiles may provide 
potential benefits.  
4. Placental macrophages 
In adult tissues, macrophages coordinate tissue homeostasis and orchestrate host defense 
and wound healing. During fetal development, macrophages are abundantly present in the 
pregnant uterus and placenta. These placental macrophages play a key role in synthesis of 
vital mediators involved in the establishment and maintenance of pregnancy, parturition, 
lactation, local immune reactions, and maternal-fetal tolerance.  
Although they exhibit their own, unique phenotypic profile, placental macrophages display 
key features of many other tissue macrophages. These characteristics include growth with 
stimulation by colony-stimulating factor-1, expression of Fc receptors and phagocytosis, and 
expression of macrophage markers (CD14, CD11b/Cd18, and F4/80) (Chang et al., 1993).  
4.1 Origins of placental macrophages 
In the human placenta, macrophages have been detected as early as day 10 of pregnancy 
and many of these macrophages are present throughout pregnancy (Chang et al., 1993)  
Placental macrophages reside within fetal chorionic villi and uterine decidua during 
pregnancy, where they assist placental development, manage host defense, and maintain 
pregnancy.  
Fetal placental macrophages and maternal placental macrophages reach the placenta by 
different routes. During prenatal development, monocyte progenitors originate in the 
hypoblast-derived fetal yolk sac and migrate to the mesenchymal core of fetal chorionic villi 
in the placenta. These placental macrophages on the fetal side are called Hofbauer cells. 
Placental macrophages on the maternal side of the placenta are derived from hematopoietic 
pluripotent stem cells that differentiate into monocyte progenitors, which will mature and 
leave the bone marrow to enter the blood. After an approximate  8 hour migration through 
the circulatory system, the maturing monocyte will enter various organs and tissues, such as 
the uterine endometrial stroma, where tissue-specific factors will further induce 
differentiation to form a tissue macrophage (Figure 3) (McIntire et al., 2006). 
4.2 General functions of placental macrophages 
Macrophages are present in many tissues, including the placenta, and make up a dynamic 
and heterogenous population of cells. Macrophage phenotypes and functions, which are 
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induced at least in part by the surrounding micro-environmental milieu, are crucial in 
inflammation, immunity, and wound healing. Macrophages are induced by environmental 
cues to regulate expression of growth factors, chemokines, cytokines, proteolytic enzymes, 
adhesion molecules, and phagocytic receptors (Martinez et al., 2009).  
 
 
Fig. 3. Placental macrophages originate from two different sources. Hofbauer cells originate 
from yolk sac cells that migrate to ultimately take up residence in the fetal chorionic villi of 
the placenta. Decidual macrophages are bone marrow-derived and take up residence in the 
uterine endometrial stroma of the placenta’s decidua basalis.  
Macrophages are abundant in the placenta and play a large role through regulation of 
immune cells and tissue growth. Placental macrophages are influential in many processes, 
including implantation, trophoblast function, placenta construction (via induction of 
angiogenesis), maternal-fetal tolerance, fetal defense/protection from infection, and 
parturition (Bulmer & Johnson, 1984; Mues et al., 1989; Sevala et al., 2007; Kzhyshkowska et 
al., 2008; Nagamatsu & Schust, 2010; Garcia et al., 1993). Placental macrophages are pivotal 
to many of these processes because of their plasticity and ability to switch phenotypes 
based on surrounding micro-environmental cues. For example, decidual placental 
macrophages respond to placental stimuli that control maternal immune reponses to the 
fetus (maternal-fetal tolerance) as well as to pathogenic stimuli during infections (host 
defense). During pregnancy, placental macrophages are exposed to local stimuli that induce 
an array of macrophage phenotypes with M1 and M2 characteristics. Placental macrophages 
express surface markers and secrete mediators such as cytokines, prostaglandins, proteolytic 
enzymes, and chemokines (McIntire et al., 2006). It should be noted that while 
microenvironmental modulation of placental macrophages plays an important role in 
regulating macrophage phenotype, it is also possible that selective recruitment of distinct 
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monocyte sub-populations might also play role. The nature of the monocyte precursor 
subpopulations that give rise to resident placental macrophages has not been studied in 
detail, and the role of local proliferation of macrophages in the placenta versus recruitment 
of new macrophages from the circulation in the maintenance of macrophage homeostasis is 
not yet clear. 
4.2.1 Placental macrophages in placenta construction 
Macrophages are abundant in fetal tissue and these macrophages play a role in placental 
development. Angiogenesis is critical for vascular development in the fetal chorionic villi of 
the placenta and is induced by secretion of VEGF from nearby Hofbauer cells located in the 
chorionic villus mesenchyme. VEGF binds the fms-like tyrosine kinase 1 receptor (Flt-1), 
which is expressed on trophoblast and endothelial cells during early pregnancy (Clark et al., 
1986). Interestingly, the placenta produces elevated levels of soluble Flt-1 receptor (sFlt-1) in 
women with pre-eclampsia. This sFlt-1 sequesters VEGF and results in dysfunctional 
angiogenesis in the placenta (Luttun and Carmeliet, 2003)  Placental development 
progresses (apoptosis, phagocytosis, matrix degradation, remodeling) via continued 
interactions between maternal decidual placental macrophages and fetal-derived 
trophoblasts (Nagamatsu & Schust, 2010).  
In addition to secretion of angiogenic factors by fetal Hofbauer cells that  promote 
angiogenesis during placental development, maternal decidual placental macrophages also 
contribute to angiogenesis in the placenta by the abundant expression of the stabilin-1 
scavenger receptor. Stabilin-1 is a receptor for placental lactogen (PL), a prolactin growth 
hormone secreted by trophoblasts. PL is important for placental angiogenesis, as seen by 
the correlation between low PL concentrations and aberrant placental angiogenesis leading 
to intrauterine growth restriction. PL is also involved in post-natal growth and 
mammogenesis/lactogenesis (Kzhyshkowska et al., 2008). Stabilin-1 binds and endocytoses 
PL. Internalized PL within the decidual macrophage can then proceed through a 
degradation pathway in which PL within lysosomes is enzymatically digested or through a 
storage pathway in which PL migrates to the trans-Golgi network for processing to be stored 
within secretory vesicles until called upon for release by low extracellular PL concentrations. 
Therefore, stabilin-1 expression on decidual M2 macrophages may serve as a sensor to 
regulate extracellular PL (through endocytosis and intracellular sorting of PL) and result in 
further regulation of factors involved in angiogenesis during placental growth 
(Kzhyshkowska et al., 2008). 
4.2.2 Placental macrophages in maternal-fetal tolerance 
There are multiple factors involved in maternal-fetal tolerance. Decidual placental 
macrophages are an integral component for suppression of the maternal immunologic 
response to the allogenic placenta and fetus. Macrophages are antigen presenting cells 
(APCs) that often activate T cells to initiate an adaptive immune response. However, 
although decidual placental macrophages constitutively express major histocompatibility 
complex class II molecules, they have a decreased ability to present antigens to T cells. As a 
result, T lymphocyte activation does not occur and the allogenic fetus is protected from 
rejection by the maternal immune system. Another result of placental macrophage inability 
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to present antigen to T cells is the inability of placental macrophages to induce an efficient 
immune response against Listeria monocytogene despite expressing MHC class II molecules 
(Chang et al., 1993; Nagamatsu & Schust, 2010) Furthermore, placental macrophages express 
higher levels of indole 2,3 dioxygenase (IDO), which catabolizes L-tryptophan. L-
tryptophan is required for T-cell activation and inhibition of IDO correlated to rejection of 
the fetus by the mother (Gordon et al., 2003).  
4.2.3 Placental macrophages as a barrier to infection 
The main defenders against infection of the placenta are placental macrophages. Among 
many other functions, macrophages play a vital role in removal of nonself as well as 
unwanted self-ligands through expression of scavenger receptors and other receptors that 
are targeted for pathogen binding, such as Toll-like receptors (e.g., TLR4 bind LPS) and 
chemokine-CC motif-receptor 5 (CCR5) (HIV-1 infection requires surface expression of 
CCR5 and CD4). While sometimes displaying a weak barrier to some pathogens like 
Listeria monocytogenes, placental macrophages often show a strong barrier to numerous 
bacterial and viral infections (Garcia-Crespo et al., 2009; Kzhyshkowska et al., 2008).   
Although macrophages are primary targets for viral infection, placental macrophages are 
less susceptible to HIV-1 infection (and other viral infections) than other macrophages. The 
placenta is often a barrier to viral replication, and viral transmission from mother to infant 
often occurs during the birth. Placental macrophages show lower levels of susceptibility to 
HIV-1 infection than monocyte-derived macrophages and this may be attributed to differing 
phenotypes. Although there are lower levels of CD4 and CCR5 expression in placental 
macrophages, it has been suggested that the mode of HIV-1 restriction in the placenta occurs 
at the transcriptional level. HIV-1-infected placental macrophages and monocyte-derived 
macrophages show different protein secretion profiles. Peroxiredoxins are antioxidant 
molecules that are more abundantly associated with placental macrophages compared to 
monocyte-derived macrophages. Also, some peroxiredoxins (1,2, and 4) have been shown to 
have anti-viral activity against HIV-1. Compared to monocyte-derived macrophages, 
placental macrophages show abundant secretion of peroxiredoxin 5. The up-regulated 
secretion of peroxiredoxin and its protective role against HIV-1 in the placenta may be 
through suppression of TNF--induced transcriptional activity of nuclear factor-kappa light 
chain enhancer of activated B cells (NF-B). In fact, although there appears to be no 
difference in viral integration for placental macrophages versus other monocyte-derived 
macrophages, there is reduced viral protein expression in placental macrophages. Therefore, 
HIV-1 restriction appears to be occuring in placental macrophages at the transcriptional 
level. NF-B is required for viral transcription of HIV-1 and suppression may lead to 
inefficient HIV-1 replication in placental macrophages. TNF--induced transcriptional 
activity of NF-B may also be thwarted in placental macrophages by down-regulation of 
cystatin B. Cystatin B induces NO production in macrophages, which up-regulates TNF-. 
Reduced HIV-1 replication has been correlated with cystatin B down-regulation and 
increased HIV-1 replication is enhanced by NO synthesis in macrophages. These factors 
(among others) distinguish placental macrophages from other macrophages and are 
influential in the restriction of HIV-1 (and perhaps other viruses) in the placenta (Garcia et 
al, 2009; Garcia-Crespo et al., 2010). 
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4.2.4 Placental macrophages as a mediator in parturition and other signaling/hormone 
Placental macrophages exhibit varying phenotypes throughout pregnancy. Placental 
macrophages are stimulated by changes in the micro-environment to switch phenotypes at 
varying stages of pregnancy as well as during aberrant activity. During late pregnancy, 
placental macrophage activity is switched to play a role in parturition through production of 
pro-inflammatory cytokines and prostaglandin E2. Altered placental macrophage 
phenotypes are also linked to the pathologic disease such as preeclampsia (Nagamatsu & 
Schust, 2010; Wetzka et al., 1997). 
During most of pregnancy placental macrophages have an M2-like immunosuppressive 
gene expression profile (such as IL-10 secretion). However, decidual placental macrophages 
may expess pro-inflammatory characteristics. For example, CD11cHI decidual placental 
macrophages may express pro-inflammatory and antigen-presenting genes while CD11cLO 
decidual placental macrophages express anti-inflammatory and tissue repair genes (Houser 
et al., 2011). It is important to recognize that classification of placental macrophages is 
complex and dependent on multiple factors, such as location within the placenta, stage of 
pregnancy, and factors (e.g., hormones and hypoxia) that change the surrounding micro-
environment. Differential recruitment of distinct monocyte sub-populations may also play 
a role, as mentioned earlier. 
4.3 M2-type placental macrophages 
Placental macrophages display polarization towards an alternatively-activated, M2 
phenotype. Hofbauer cells (fetal placental macrophages within chorionic villi) and decidual 
macrophages (maternal placental macrophages within the endometrial decidual stroma) are 
both classified as M2/alternatively-activated macrophages (Joerink et al., 2011; Gustafsson 
et al., 2011). The role of IL-4 in polarization of placental macrophages is blurred by variable 
placental macrophage phenotypic profiles. Although IL-4 is involved in endocytosis of 
stabilin-1-bound PL by placental macrophages, decidual macrophages induced via IL-4-
independent means display different expression profiles than those seen with IL-4 
stimulation, indicating that a Th2 environment is not required for decidual macrophage 
development (Svensson et al., 2011; Kzhyshkowska et al., 2008).  
As M2 macrophages, the placental macrophage profile typically shows down-regulation 
of pro-inflammatory mediators and up-regulation of mediators that are 
immunosuppressive and anti-inflammatory. However, as with many other tissue 
macrophages, a placental macrophage does not exhibit a phenotype extreme that solely 
expresses M2 markers. Placental macrophages may express M1 markers, but the 
representative expression pattern emphasizes many M2 markers. The placental 
macrophage M2 marker expression is regulated by activating agents (such as cytokines, 
hormones, and adenosine) in the surrounding micro-environment in a manner that yields 
an M2 phenotype profile that is distinct from other M2 macrophages. The exact nature 
and combinations of activating agents to achieve this unique profile has yet to be 
completely elucidated. Analyses of M2 placental macrophages from normal pregnancies 
and pregnancies with complications have shed some light on dysregulation. In fact, a 
correlation between dysregulation of some placental macrophage markers and 
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preeclampsia (MR, CCL2, IGF-1, MMP9), pre-term labor (CCL18) and intrauterine growth 
restriction (IGF-1) has been shown (Gustafsson et al., 2011).  
Placental macrophages typically lack or exhibit low expression of pro-inflammatory M1 
markers (such as CX3CR1, IL-7R and CCR7), as described in Hofbauer cells by Joerink et al. 
(2011). Many placental macrophage M2 markers have been investigated. A number of M2 
markers have been identified in placental macrophages such as DC-SIGN (attachment factor 
for HIV-1 entry), CD163 and mannose receptor/CD206, stabilin-1, CCL18 (involved in 
tolerance of T lymphocytes with reduced expression after the onset of labor), CD209, 
fibronectin-1 and insulin-like growth factor-1 (IGF-1), TREM-2, alpha 2 macroglobulin 
(A2M), prostaglandin D2 synthase (PGDS), and IL-10 (Kzhyshkowska et al., 2008; 
Gustafsson et al., 2011; Svensson et al., 2011; Joerink et al., 2011). Recall that placental 
macrophages are not at the extreme end of the M2 spectrum of macrophages and that M1-
type markers can also be seen in placental macrophage populations. For example, placental 
macrophages express IL-6 and CCL2 (aka monocyte-chemoattractant protein-1, MCP-1), 
which are typically pro-inflammatory M1 markers. It has been suggested that CCL2 
expression by placental macrophages may be important for monocyte recruitment to 
decidua and that macrophage phenotypes may then be altered by other environmental 
factors upon arrival (Svensson et al., 2011; Gustafsson et al., 2011). Furthermore, Houser et 
al. (2011) have characterized decidual placental macrophages as having profiles associated 
with M1 and M2 macrophages. As mentioned previously,  CD11cHI decidual macrophages 
are pro-inflammatory while CD11cLO decidual macrophages are anti-inflammatory. Thus, 
decidual macrophages have varying phenotypes that help to coordinate maternal-fetal 
interactions at the placenta (Houser et al., 2011).  
5. Research and clinical implications  
5.1 Advantages and limitations of experimental models/materials 
It should be emphasized that some limitations to consider in the characterization of 
alternatively-activated macrophages include species-species variation in gene expression 
patterns and variable effects of the micro-environment surrounding macrophages. 
Investigation of M1 and M2 marker expression has been focused more predominantly using 
murine macrophages and human homologs for some murine markers have not been found  
(Martinez et al., 2009).  
Furthermore, agents in the environment surrounding macrophages influence macrophage 
activation, and while in vitro models are useful, analyses obtained from them are limited. 
Macrophages in culture enable investigators to highlight activation factors and gene 
expression patterns; however, absence of in vivo models may overlook interactions with 
other cell types and the mediators that they may elaborate. It is crucial to investigate 
interactions of expressed proteins that may be different in an in vivo  context in which there 
may be interaction with other cells or mediators. Macrophage activation is a complex and 
dynamic enterprise with characteristics that vary with time to result in early and late 
markers. For example, expression of CCL18 in decidual macrophages declines with onset of 
labor (Gustaffson et al., 2011). Macrophage phenotype switching is driven in a temporally-
orchestrated manner that depends upon alterations in the micro-environment, such as that 
seen in the changing placenta.  
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5.2 Clinical implications and future research 
M1 and M2 macrophages are pivotal players in host defense, wound repair, and 
pregnancy and further investigation into these polarized activated macrophage 
phenotypes may elucidate normal and variant processes. Knowledge of processes 
associated with placental macrophages may shed light on pathological mechanisms and 
may present attractive potential pharmaceutical targets to regulate disease. For example, 
decidual macrophages with overexpression of M1 markers have been implicated in 
parturition and early embryo loss (Gustaffson et al., 2011). Thus, manipulation of 
placental macrophage phenotypes by modulating signaling pathways in macrophages or 
by altering the surrounding environment may provide therapeutic benefits. For example, 
because of their angiogenic effects, induction of M2 macrophages phenotypes may 
enhance placental growth.  
6. Conclusion 
Macrophages are found throughout the body and exhibit a broad spectrum of phenotypes 
based in large part  on the surrounding microenvironment. Placental macrophages exhibit a 
phenotypic profile more characterisitic of M2 macrophages that are immunomodulatory 
and promote angiogenesis for placental development. Investigation of placental 
macrophages may provide insight into normal development as well as possible causes of 
embryo loss. 
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